Harrow Health, Inc. (HROW) NASDAQ

39.77

+2.78(+7.52%)

Updated at September 08 04:00PM

Currency In USD

Valuation

Market Cap1.2B
Enterprise Value1.38B
P/E Ratio-143.05
PEG Ratio-2.73
Price/Sales Ratio6.46
Price/Book Ratio29.47
Enterprise/Revenue7.25
Enterprise/EBITDA51.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.04
Operating Margin0.06

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.18

Income Statement

Revenue199.61M
Revenue/Share6.19
Gross Profit150.37M
EBITDA19.28M
Net Income-17.48M
Diluted EPS-0.49

Balance Sheet

Total Cash52.96M
Total Cash/Share1.44
Total Debt231.25M
Total Debt/Equity4.66
Current Ratio0.62
Book Value Per Share1.34

Price History

52-Week Change1.14
52-Week High59.23
52-Week Low20.85
Moving Average 50 Days35.12
Moving Average 200 Days31.51

Statistics

Average Volume498,788
Shares Outstanding37M
% Held by Institutions53.41

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:5
Last Split DateFebruary 08, 2013